GlassScriptPhysician profile
Rae D Talley
NPI 1417283987
$1,498.95
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $278 · 2022: $458 · 2023: $668 · 2024: $94.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $247.51 | 2021-2023 | Jardiance, Emgality, Mounjaro |
| Novo Nordisk INC | $220.96 | 2021-2022 | |
| Abbott Laboratories | $187.13 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $152.39 | 2021-2024 | Xifaxan |
| Abbvie INC. | $151.03 | 2021-2024 | |
| Amgen INC. | $113.11 | 2021-2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $81.93 | 2022-2023 | Shingrix |
| Merck Sharp & Dohme LLC | $47.05 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $45.74 | 2021-2023 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $44.72 | 2022 | |
| Pfizer INC. | $42.80 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.10 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.10 | 2021-2022 | |
| Exact Sciences Corporation | $27.55 | 2023 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $21.36 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $21.16 | 2023 | Rexulti |
| Shield Therapeutics INC | $15.31 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rae Talley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.